Suppr超能文献

环糊精-普朗尼克聚醚共聚物聚集体的药物增溶与递送

Drug solubilization and delivery from cyclodextrin-Pluronic aggregates.

作者信息

Rodriguez-Perez A I, Rodriguez-Tenreiro C, Alvarez-Lorenzo C, Concheiro A, Torres-Labandeira J J

机构信息

Departamento de Farmacia y Tecnología Farmacéutica, Facultad de Farmacia, Universidad de Santiago de Compostela, 15782-Santiago de Compostela, Spain.

出版信息

J Nanosci Nanotechnol. 2006 Sep-Oct;6(9-10):3179-86. doi: 10.1166/jnn.2006.472.

Abstract

Colloidal systems based on Pluronic F127 (PF127) and hydroxypropyl-beta-cyclodextrin (HPbetaCD) have been characterized with a view to their potential use as delivery systems of hydrophobic drugs. Complexation of PF127 and HPbetaCD was evaluated by surface tension measurements, 1H-NMR spectroscopy and transmission electron microscopy. The critical micellar concentration, CMC, at 25 degrees C of PF127 (0.39 mM in pH 5.8 and 7.4 phosphate buffers, and 0.59 mM in pH 4.5 acetic/acetate and lactic/lactate buffers) was shifted to higher values by the addition of 38.17 mM HPbetaCD (CMC(app) = 1.18 mM). This is related to the threading of HPbetaCD onto the PF127 chains, as confirmed by 1H NMR experiments. HPbetaCD at this concentration notably raised the sol-gel transition temperature; the minimum PF127 concentration required for providing gelling systems in physiological environments being 13.4 mM. Both HPbetaCD and PF127 by themselves are able to notably increase the solubility of sertaconazole (SN). At HPbetaCD concentrations below 80 mM, an additive effect of both components on SN solubility was observed. At greater HPbetaCD concentrations, a non-additive increase occurred, which is related to the complexation of some PF127 unimers with HPbetaCD molecules, decreasing the total number of micelles and HPbetaCD cavities available for interacting with SN. The 13.4 mM PF127/38.17 mM HPbetaCD system, able to increase up to 100 times the SN solubility in pH5.8 phosphate buffer, showed temperature-dependent drug diffusion coefficients, able to control the release for one week at 37 degrees C.

摘要

基于泊洛沙姆F127(PF127)和羟丙基-β-环糊精(HPβCD)的胶体系统已被表征,以期用作疏水药物的递送系统。通过表面张力测量、1H-NMR光谱和透射电子显微镜对PF127和HPβCD的络合进行了评估。在25℃下,PF127的临界胶束浓度(CMC)(在pH 5.8和7.4的磷酸盐缓冲液中为0.39 mM,在pH 4.5的乙酸/乙酸盐和乳酸/乳酸盐缓冲液中为0.59 mM)通过添加38.17 mM的HPβCD而移至更高值(CMC(app)= 1.18 mM)。1H NMR实验证实,这与HPβCD穿入PF127链有关。该浓度的HPβCD显著提高了溶胶-凝胶转变温度;在生理环境中提供凝胶系统所需的最低PF127浓度为13.4 mM。HPβCD和PF127自身都能够显著提高舍他康唑(SN)的溶解度。在HPβCD浓度低于80 mM时,观察到两种成分对SN溶解度的加和效应。在更高的HPβCD浓度下,出现非加和性增加,这与一些PF127单聚体与HPβCD分子的络合有关,减少了可用于与SN相互作用的胶束和HPβCD空腔的总数。13.4 mM PF127/38.17 mM HPβCD系统能够使SN在pH5.8磷酸盐缓冲液中的溶解度提高多达100倍,显示出温度依赖性的药物扩散系数,能够在37℃下控制释放一周。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验